Frederick Finnegan Sab Biotherapeutics, Inc. (SABS) insider trading activity

SABS Quotes by TradingView

Frederick Finnegan is Chief Business Officer of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 38,596 shares of SABS, which is worth approximately $118,103. The most recent transaction as insider was on Oct 22, 2021, when has been sold 38,596 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.6K
0% 3M change
0% 12M change
Total Value Held $118,103

Frederick Finnegan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2021
BUY
Grant, award, or other acquisition
-
38,596 Added 50.0%
38,596 Common Stock
FF

Frederick Finnegan

Chief Business Officer
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SABS